Name
CAR-T
Alternate Names
Chimeric antigen receptor T-cell therapy
KTE-C19
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
None
NSC Number
None
Primary Site
None
Histology
Remarks
8/30/2017: Food and Drug Administration approved CAR-T cell therapy for children and young adults with B-cell acute lymphoblastic leukemia (ALL).
Coding
This drug should be coded